Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Bocksrucker, C; Lampl, C; Storch, MK; Stojakovic, T; Fazekas, F.
Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.
PLoS One. 2013; 8(7):e68768-e68768
Doi: 10.1371/journal.pone.0068768
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Pekar Thomas
- Seifert-Held Thomas
- Co-Autor*innen der Med Uni Graz
- Fazekas Franz
- Gattringer Thomas
- Scharnagl Hubert
- Simmet Nicole
- Stojakovic Tatjana
- Storch Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- To evaluate if plasma levels of midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke. In 168 consecutive ischemic stroke patients, plasma levels of MR-proADM were measured within 24 hours from symptom onset. Functional outcome was assessed by the modified Rankin Scale (mRS) at 90 days following stroke. Logistic regression, receiver operating characteristics (ROC) curve analysis, net reclassification improvement (NRI), and Kaplan-Meier survival analysis were applied. Plasma MR-proADM levels were found significantly higher in patients with unfavourable (mRS 3-6) compared to favourable (mRS 0-2) outcomes. MR-proADM levels were entered into a predictive model including the patients' age, National Institutes of Health Stroke Scale (NIHSS), and the use of recanalization therapy. The area under the ROC curve did not increase significantly. However, category-free NRI of 0.577 (p<0.001) indicated a significant improvement in reclassification of patients. Furthermore, MR-proADM levels significantly improved reclassification of patients in the prediction of outcome by the Stroke Prognostication using Age and NIHSS-100 (SPAN-100; NRI = 0.175; p = 0.04). Kaplan-Meier survival analysis showed a rising risk of death with increasing MR-proADM quintiles. Plasma MR-proADM levels improve prediction of functional outcome in ischemic stroke when added to the patients' age, NIHSS on admission, and the use of recanalization therapy. Levels of MR-proADM in peripheral blood improve reclassification of patients when the SPAN-100 is used to predict the patients' functional outcome.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adrenomedullin - blood
- Adult -
- Aged -
- Aged, 80 and over -
- Brain Ischemia - complications
- Female -
- Humans -
- Kaplan-Meier Estimate -
- Male -
- Middle Aged -
- Prognosis -
- Protein Precursors - blood
- Stroke - blood
- Young Adult -